Ikena Oncology, Inc. Profile Avatar - Palmy Investing

Ikena Oncology, Inc.

Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the tran…

Biotechnology
US, Boston [HQ]
Value per Employee (VpE) · Surveys · Talents

Employees Analysis

Employee Surveys

Employees Asked: -

No survey available at the moment.

End of IKNA's Analysis
CIK: 1835579 CUSIP: 45175G108 ISIN: US45175G1085 LEI: - UEI: -
Secondary Listings
IKNA has no secondary listings inside our databases.